In a filing, Pyxis Oncology Inc revealed its Director HUMPHREY RACHEL acquired Company’s shares for reported $14362.0 on Apr 21 ’25. In the deal valued at $1.03 per share,13,896 shares were bought.
Then, HUMPHREY RACHEL bought 200 shares, generating $194 in total proceeds.
Before that, HUMPHREY RACHEL bought 1,400 shares. Pyxis Oncology Inc shares valued at $1,362 were divested by the Director at a price of $0.97 per share.
William Blair downgraded its Pyxis Oncology Inc [PYXS] rating to a Mkt perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Stephens’s analysts, who began to cover the stock in early November with a ‘”an Overweight”‘ rating. Stifel began covering PYXS with “Buy” recommendation on August 08, 2024.
Price Performance Review of PYXS
On Tuesday, Pyxis Oncology Inc [NASDAQ:PYXS] saw its stock fall -3.77% to $1.02. Over the last five days, the stock has gained 11.48%. Pyxis Oncology Inc shares have fallen nearly -34.62% since the year began. Nevertheless, the stocks have fallen -77.48% over the past one year. While a 52-week high of $5.39 was reached on 01/07/25, a 52-week low of $0.83 was recorded on 04/07/25. SMA at 50 days reached $1.1059, while 200 days put it at $2.4693.
Levels Of Support And Resistance For PYXS Stock
The 24-hour chart illustrates a support level at 0.9667, which if violated will result in even more drops to 0.9133. On the upside, there is a resistance level at 1.1167. A further resistance level may holdings at 1.2133. The Relative Strength Index (RSI) on the 14-day chart is 49.70, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0602, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 42.84%. Stochastics %K at 66.37% indicates the stock is a holding.
How much short interest is there in Pyxis Oncology Inc?
A steep rise in short interest was recorded in Pyxis Oncology Inc stocks on 2025-03-31, growing by 0.33 million shares to a total of 7.34 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 7.01 million shares. There was a rise of 4.47%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 09, 2024 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
